3Ogawa S,Kurokawa M,Tanaka T,et al.Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.Leukemia,1996,10:788-794.
4Nakamura Y,Nakazato H,Sato Y,et al.Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13).Am J Hematol,2002,69:80-82.
5Secker-Walker LM.General Report on the European Union Concerted Action Workshop on 11q23,London,UK,May 1997.Leukemia,1998,12:776-778.
6Soekarman D,von Lindern M,Daenen S,et al.The translocation (6;9)(p23;q34)shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features.Blood,1992,79:2990-2997.
5Pallisgaard N, Horland P, Riishoj DC, et al. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood, 1998, 92: 574-588.
6Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO)classification of the myeloid neoplasms. Blood, 2002, 100: 2292-2302.
7Bienz M, Ludwig M, Leibunclgut EO, et al. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res, 2005,11: 1416-1424.
8Pallisgaard N,Horland P,Riishoj DC,et al. Multiplex reverse transcription polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia[J]. Blood, 1998, 92(2 ) : 574-588.
9Vardiman JW,Harris NL,Brunning RD. The World Heolth Organization (WHO)classification of the myeloid neoplasms[J]. Blood ,2002,100(7 ): 2292-2302.
10Bienz M,Ludwig M, Mueller BU,et al. Risk assessment in patients with acute myeloid leukemia and a normal karyotype[J]. Clin Cancer Res, 2005, 11(4) : 1416-1424.
